Progyny (PGNY): Buy, Sell, or Hold Post Q4 Earnings? [Yahoo! Finance]
Progyny, Inc. (PGNY)
Last progyny, inc. earnings: 3/5 04:06 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Its shares have yielded a 40% return over the last six months, beating the S&P 500 by 54.3%. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move. Is now the time to buy Progyny, or should you be careful about including it in your portfolio? Check out our in-depth research report to see what our analysts have to say, it's free We're glad investors have benefited from the price increase, but we're cautious about Progyny. Here are three reasons why there are better opportunities than PGNY and a stock we'd rather own. Pioneering a data-driven approach to family building that has achieved an industry-leading patient satisfaction score of +80, Progyny (NASDAQ:PGNY) provides comprehensive fertility and family building benefits solutions to employers, helping employees access quality fertility treatments and support services. Larger companies benefit from economies of scale, where fixed costs like infrastructure, techno
Show less
Read more
Impact Snapshot
Event Time:
PGNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PGNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PGNY alerts
High impacting Progyny, Inc. news events
Weekly update
A roundup of the hottest topics
PGNY
News
- Progyny (NASDAQ:PGNY) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.MarketBeat
- Progyny (NASDAQ:PGNY) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.MarketBeat
- Progyny (PGNY): Reassessing Valuation After a Strong Year and Recent Pullback in the Share Price [Yahoo! Finance]Yahoo! Finance
- Progyny (PGNY) Q3 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- New Men’s Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and ActionGlobeNewswire
PGNY
Earnings
- 11/6/25 - Beat
PGNY
Sec Filings
- 12/15/25 - Form 4
- 12/11/25 - Form 144
- 12/8/25 - Form 4
- PGNY's page on the SEC website